Quantitative Spectrochip-Coupled Lateral Flow Immunoassay Demonstrates Clinical Potential for Overcoming Coronavirus Disease 2019 Pandemic Screening Challenges

As coronavirus disease 2019 (COVID-19) continues to spread around the world, the establishment of decentralized severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) diagnostics and point-of-care testing is invaluable. While polymerase chain reaction (PCR) has been the gold standard for COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Kai-Feng, Hung, Chih-Hsing, Hong, Chitsung, Chen, Szu-Chia, Sun, Yi-Chen, Wen, Jyun-Wei, Kuo, Chao-Hung, Ko, Cheng-Hao, Cheng, Chao-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003115/
https://www.ncbi.nlm.nih.gov/pubmed/33803850
http://dx.doi.org/10.3390/mi12030321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003115/
https://www.ncbi.nlm.nih.gov/pubmed/33803850
http://dx.doi.org/10.3390/mi12030321

Ejemplares similares